Sign in

CIK 0000907654

  • Non-accelerated filer
  • Smaller reporting company

Oruka Therapeutics, Inc.

Sign in to watch
Ticker
ORKA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
363855489
Phone
+1 650-606-7910
Business address
855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
Former names
ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Open-market buy Director bought 10,000 shares at $4.16 ($41,630)
  6. 4 Open-market buy Director bought 5,000 shares at $4.28 ($21,400)
  7. 4 Open-market buy Director bought 3,056 shares at $4.66 ($14,241)
  8. 4 Open-market buy Director bought 10,000 shares at $4.77 ($47,660)
  9. 4 Open-market sale Chief Operating Officer sold 482 shares at $0.50 ($242)
  10. 4 Open-market sale VP, Finance sold 1,114 shares at $0.50 ($556)
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Open-market sale Chief Operating Officer sold 410 shares at $0.72 ($294)
  17. 4 Open-market sale VP, Finance sold 161 shares at $0.53 ($85)
  18. 4 Open-market sale 10% owner sold 1,541,331 shares at an average $0.55 ($846,905)
  19. 4 Open-market sale 10% owner sold 1,460,209 shares at $0.50 ($731,273)
  20. 4 Open-market sale 10% owner sold 1,460,209 shares at $0.50 ($731,273)

Page 8 of 23 · 459 filings